Myeloid growth factors for CAR-T therapy

C

Recommendations on the use of growth factor after CAR T
cell infusion vary, with some experts administering filgrastim
as standard of care during periods of neutropenia and others
recommending filgrastim only for patients with neutropenic
fever

Current status and hurdles for CAR-T cell immune therapy Blood Science: October 2019 – Volume 1 – Issue 2 – p 148-155 Biology of Blood and Marrow Transplantation Volume 25, Issue 1, January 2019, Pages 26-33

Categories

Blog Archives